2. THE PRINCIPLES OF ICH GCP
2.1 Clinical trials should be conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki, and that are consistent with GCP and the applicable regulatory requirement(s).
2.2 Before a trial is initiated, foreseeable risks and inconveniences should be weighed against the anticipated benefit for the individual trial subject and society. A trial should be initiated and continued only if the anticipated benefits justify the risks.
2.3 The rights, safety, and well-being of the trial subjects are the most important considerations and should prevail over interests of science and society.
2.4 The available nonclinical and clinical information on an investigational product should be adequate to support the proposed clinical trial.
2.5 Clinical trials should be scientifically sound, and described in a clear, detailed protocol.
2.6 A trial should be conducted in compliance with the protocol that has received prior institutional review board (IRB)/independent ethics committee (IEC) approval/favourable opinion.
2.7 The medical care given to, and medical decisions made on behalf of, subjects should always be the responsibility of a qualified physician or, when appropriate, of a qualified dentist.
2.8 Each individual involved in conducting a trial should be qualified by education, training, and experience to perform his or her respective task(s).
2.9 Freely given informed consent should be obtained from every subject prior to clinical trial participation.
2.10 All clinical trial information should be recorded, handled, and stored in a way that allows its accurate reporting, interpretation and verification.
This principle applies to all records referenced in this guideline, irrespective of the type of media used.
2.11 The confidentiality of records that could identify subjects should be protected, respecting the privacy and confidentiality rules in accordance with the applicable regulatory requirement(s).
2.12 Investigational products should be manufactured, handled, and stored in accordance with applicable good manufacturing practice (GMP). They should be used in accordance with the approved protocol.
2.13 Systems with procedures that assure the quality of every aspect of the trial should be implemented.
Aspects of the trial that are essential to ensure human subject protection and reliability of trial results should be the focus of such systems.
NCT04498819Not yet recruitingConditions: Type 2 Diabetes; Comorbidities and Coexisting Conditions
NCT04498832Not yet recruitingStudy to Assess the Immuno Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and OlderConditions: Influenza (Healthy Volunteers)
NCT04498845Not yet recruitingConditions: Lead Poison Children
NCT04498858Not yet recruitingConditions: Tobacco Cessation; Dental Practice
NCT04498871AvailableConditions: Hypereosinophilic Syndrome (HES)
NCT04498884CompletedComparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp MethodConditions: Bioequivalence
NCT04498897RecruitingConditions: Depressive Disorder, Major; Alcoholism
NCT04498910Not yet recruitingConditions: Migraine
NCT04498923RecruitingConditions: Postoperative Pain; Peripheral Neuropathy; Fractures of the Upper Limb; Fracture of the Lower Limb (Except Hip), Initial Encounter; Intraoperative Hypotension; Intraoperative Hypertension; Pain Syndrome; Anesthesia; Anesthesia, Local; Local Anesthetic Systemic Toxicity
Featured Contract Research Organizations
The name Solvias is derived from the Latin terms ‘solutio’ and ‘via’ – it is our promise to explore new ways to find solutions that fulfill your requi...
Theradex was founded in 1982 with the award of the Clinical Trials Monitoring Service contract for the National Cancer Institute (NCI) in the United S...
Medelis is a full service oncology clinical research company. We provide sponsors with a highly-skilled and proactive oncology clinical trial manageme...
Medi Service S.r.l. is a full-service Clinical Research Organisation (CRO) founded in 1991. Its main functions such as Clinical Operations, Finance an...